Is Afya Limited (AFYA) a good stock to buy?

Olyth's institutional analysis of AFYA reveals an Altman Z-Score of 2.33 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($3.62B most recent), help investors decide if AFYA fits their risk profile.

What is the current P/E ratio for AFYA?

As of the latest trading session, Afya Limited (AFYA) has a trailing P/E ratio of 9.20.

Who is the CEO of Afya Limited?

The current Chief Executive Officer of Afya Limited is Virgilio Deloy Capobianco Gibbon.

What was AFYA's revenue for the last 5 years?

According to its latest income statements, Afya Limited reported annual revenues of $3.62B (2025), $3.30B (2024), $2.88B (2023), $2.33B (2022), $1.72B (2021) respectively.

Does AFYA pay a dividend?

Afya Limited currently pays a dividend to its shareholders, with a trailing dividend yield of 4.41%.

How much debt and cash flow does AFYA have?

In its latest reporting period, Afya Limited generated $1.04B in Free Cash Flow against a total debt load of $3.12B.

What is the Price-to-Book (P/B) ratio of Afya Limited?

The Price-to-Book (P/B) ratio for Afya Limited (AFYA) is currently 1.43.

What is the Price-to-Sales (P/S) ratio of AFYA?

Based on trailing twelve-month data, Afya Limited (AFYA) trades at a Price-to-Sales (P/S) ratio of 1.88.

What is Afya Limited's Return on Equity (ROE)?

Afya Limited (AFYA) has a Return on Equity (ROE) of 16.24%, representing its profitability relative to shareholder equity.

AFYA

Afya Limited · Consumer Defensive

14.89

0.70%(-0.10)

Market Open

Last Updated: — ET

52W L: $13.0052W H: $19.90

$14.86

CHG+1.19 (+8.68%)

H$15.61

L$13.42

VOL1.8M

AFYA (1h)

Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Sector

Consumer Defensive

Industry

Education & Training Services

Employees

5,260

IPO Date

2019-07-19

Beta

0.51

Websitewww.afya.com.br↗

Market Stats

Market Cap1.3B

Volume111K

Avg Volume117K

Open$14.93

Prev Close$14.99

EPS12.79

P/E9.20

50D MA$14.48

200D MA$14.97

Insider Activity

Gibbon Virgilio Deloy Capobianco